Viewing Study NCT06824168


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2025-12-28 @ 5:55 PM
Study NCT ID: NCT06824168
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Sponsor: Daiichi Sankyo
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module